Mounjaro/Zepbound Tracker App
Track Your Mounjaro/Zepbound Protocol
Mounjaro/Zepbound (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Mounjaro/Zepbound protocol — doses, side effects, weight, and labs.
What Is Mounjaro/Zepbound?
Mounjaro/Zepbound (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Mounjaro/Zepbound protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Mounjaro/Zepbound protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Mounjaro/Zepbound protocol record from day one.
How to Track Your Mounjaro/Zepbound Protocol
Mounjaro/Zepbound Key Facts
Protocol FAQs
Clinical trials show tirzepatide produces more weight loss (22% vs 15-17%) and better A1C reduction than semaglutide. However, individual results vary. Shotlee tracks both medications.
Sulfur burps (egg-smelling burps) are a unique side effect of tirzepatide not commonly seen with semaglutide. Shotlee helps you track this and identify triggers.
Yes! Many users get tirzepatide from telehealth providers. Shotlee supports custom dosing for compounded formulations.
Mounjaro is indicated for type 2 diabetes while Zepbound is for obesity. Your doctor can help decide. Shotlee tracks both identically.
Open the Shotlee app, navigate to the dose logging screen, select Tirzepatide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Mounjaro/Zepbound Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Tirzepatide
CagriSema Breakthrough: New Dual Therapy Delivers Major Weight Loss in Diabetes Trials
Explore the groundbreaking REIMAGINE trial results for CagriSema, a novel dual-agonist therapy showing superior glycemic control and weight loss in type 2 diabetes patients.
7 min read
Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.
7 min read
Serena Williams Champions GLP-1s: Ads Air Amidst Tennis Comeback
Tennis legend Serena Williams is making waves both on and off the court. As she returns to professional tennis, advertisements featuring her advocacy for GLP-1 medications are set to air, highlighting a significant cultural moment for weight management therapies.
6 min read